Patent 7276477 was granted and assigned to Amgen on October, 2007 by the United States Patent and Trademark Office.
The present invention relates to crystalline etanercept and to methods of making crystalline etanercept; to pharmaceutical compositions comprising crystalline etanercept; and to therapeutic uses of such compositions.